ABSTRACT
Characterizing longitudinal trajectories of social exposures or health outcomes is a persistent challenge, but can be accomplished with sequence analysis, a data-driven approach that can differentiate timing, order and duration of events. We present practical guidance on implementing sequence analysis for epidemiologists with the goal of providing clear advice on decision points and tradeoffs.
We Introduce the three main steps of sequence analysis: (1) coding longitudinal processes as trajectories of ordered events for a set of individuals, (2) measuring dissimilarity between individual trajectories, and (3) performing cluster analysis to group similar trajectories. Each of these steps presents researchers with several decision points, such as data cleaning rules, options for evaluating sequence dissimilarity, and choices of clustering algorithms to group trajectories. After outlining each of the sequence analysis steps, we provide an applied example of sequence analysis in which we create and group transition-to-retirement trajectories from age 51-75 for a sample of 9,189 Health and Retirement Study participants using self-reported employment information, then estimate the association between transition-to-retirement groups and self-rated health.
Our paper seeks to guide epidemiologists through the analytic decisions and implementation challenges of sequence analysis as this approach is increasingly implemented and undergoes methodological advances.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study use only publicly available survey data, originally located on the Health and Retirement Study (HRS) website (https://hrs.isr.umich.edu/data-products).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
